Zentek (NASDAQ:ZTEK) Stock Price Up 1.5% - Here's What Happened

Key Points

• Zentek Ltd. (NASDAQ:ZTEK) shares increased by 1.5% recently, with trading prices ranging from $0.86 to $0.89.
• The company reported negative earnings per share of ($0.01) and a revenue of $0.57 million last quarter, showing a negative net margin of 1,186.72%.
• Institutional investors hold 0.77% of Zentek's stock, with Two Sigma Securities LLC recently acquiring a stake valued at approximately $31,000.

Zentek Ltd. (NASDAQ:ZTEK - Get Free Report) shares were up 1.5% during trading on Tuesday . The stock traded as high as $0.89 and last traded at $0.88. Approximately 18,284 shares were traded during trading, a decline of 47% from the average daily volume of 34,285 shares. The stock had previously closed at $0.86.

Zentek Price Performance

The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.00 and a current ratio of 1.25. The firm's 50-day simple moving average is $1.08 and its 200 day simple moving average is $1.17.

Zentek (NASDAQ:ZTEK - Get Free Report) last announced its quarterly earnings data on Thursday, August 14th. The company reported ($0.01) EPS for the quarter. Zentek had a negative net margin of 1,186.72% and a negative return on equity of 58.87%.

Institutional Trading of Zentek

An institutional investor recently bought a new position in Zentek stock. Two Sigma Securities LLC purchased a new stake in shares of Zentek Ltd. (NASDAQ:ZTEK - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 33,128 shares of the company's stock, valued at approximately $31,000. Institutional investors own 0.77% of the company's stock.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.